Sanofi has announced the launch of its inactivated rabies vaccine, Verorab, in the UK for all age groups with pre-exposure and post-exposure prophylaxis for rabies. Licensed in the UK since November ...

1. Pre-exposure prophylaxis clinical trials of a 3-dose regimen of Verorab ® followed by a booster dose at 1 year in adults and children achieved an adequate immune response. 1 2. Of those who had a ...

According to FDA advisory 2019-190, the original Verorab Rabies Vaccine for Human Use, Prepared on Cell Cultures (Inactivated) has been counterfeited. Sanofi Pasteur Inc. manufactures the authentic ...

WHO, in a medical product alert released on Tuesday, July 16, identified the human vaccines and serum in question as falsified batches of Verorab, Speeda, Rabipur, and Equirab. This comes amid a ...

As rabies remains a persistent threat in South Africa, a new vaccine, Chirorab, has been made available as an alternative amid an ongoing shortage of Verorab, according to the National Institute ...

Drug-maker Sanofi's vaccines division Sanofi Pasteur has formalised a marketing and distribution agreement with Pune's Emcure Pharmaceuticals for its anti-rabies vaccine, Verorab. The product will ...

Citing a report of the Philippines’ Food and Drug Administration (FDA) last December, WHO said that “falsified Verorab® vaccines” have been identified in the Philippines. The “genuine ...

The two partners, who have been fighting a legal battle over marketing of Aventis' anti-rabies vaccine Verorab, have agreed to settle their dispute following the deal. In a filing to the Bombay ...